1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Sunphenon: new trials by email Literature Review of Sunphenon trials Research Report on Sunphenon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study) epigallocatechin-gallate (Sunphenon), placebo - Relapsing-remitting Multiple Sclerosis | Phase 1 / Phase 2 | Completed | Charite University, Berlin, Germany | 120 | 2007-09-01 | 2021-07-29 |
Inflammation (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Nerve Degeneration (1)
Charite University, Berlin, Germany (1)
Germany (1)
Friedemann Paul, Prof., MD (1) · Judith Bellmann-Strobl, Dr., MD (1)